DAIC

DECEMBER 12, 2023

milla1cf Tue, 12/12/2023 - 07:00 December 12, 2023 — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.

Aortic valve 116

Aortic valve Aortic Blood Clot Medicare 116

DAIC

MARCH 14, 2025

Washington Convention Center in Washington, DC.

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease.

Medicare 52

Medicare Coronary Artery Disease Stenosis Aortic 52

Circulation: Cardiovascular Quality & Outcomes

MARCH 28, 2025

BACKGROUND:Although Medicare Advantage (MA) plans provide coverage to >50% of Medicare beneficiaries, it is unclear whether MA claims can be used similarly to Medicare Fee-For-Service (FFS) claims for clinical outcomes assessment. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print.

Medicare 40

Medicare Aortic valve Atrial Flutter Aortic 40

DAIC

JANUARY 29, 2024

The researchers found that Medicare patients undergoing esophagectomy for cancer exhibit identifiable predictors for long-term survival and readmission. These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

The American Journal of Cardiology

MARCH 10, 2025

Publication date: Available online 9 March 2025 Source: The American Journal of Cardiology Author(s): John Eisenga, Taylor Pickering, Kyle McCullough, Jasjit Banwait, Sarah Hale, Katherine Harrington, William Brinkman, Michael Mack, J. Michael DiMaio, Justin Schaffer

Aortic valve 40

Aortic valve Medicare Aortic 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

BACKGROUND:Food and Drug Administrationmandated postmarket studies for transcatheter aortic valve replacement in low-risk populations plan to use passively collected registry data linked to claims for long-term follow-up out to 10 years. Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025.

Aortic valve 40

Aortic valve Outcomes Pacemaker Aortic 40